Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

(*) mandatory field


Other search option(s)

Albright hereditary osteodystrophy

Orpha number ORPHA665
Synonym(s) -
Prevalence Unknown
Inheritance Autosomal dominant
Age of onset Childhood
  • E20.1
  • C2931404
  • C537045
MedDRA -


Albright hereditary osteodystrophy (AHO) is a syndrome with a wide range of manifestations including short stature, obesity, rounded face, subcutaneous ossifications and characteristic shortening and widening of long bones in the hands and feet (brachydactyly mostly affecting the 4th and 5th rays). Mental retardation was less frequently described. These somatic features are associated with resistance to PTH or parathyroid hormone (a syndrome called pseudohypoparathyroidism type 1a or PHP1a) and to other hormones (thyroid-stimulating hormone or TSH in particular). PHP1a is characterized by hypoparathyroid manifestations (hypocalcemia, hyperphosphoremia) and elevated PTH levels, indicating resistance to the hormone. Patients show decreased biological activity of the protein Gs in erythrocytes. AHO with Gs deficiency but without hormone resistance is called pseudopseudohypoparathyroidism (PPHP). AHO with hormonal resistance but normal Gs activity is called PHP-1c. PHP without AHO (and with normal levels of Gs biological activity) is generally classified as PHP-1b. AHO with decreased Gs activity is due to heterozygous inactivating mutations of the GNAS gene. This gene encodes the a-subunit of Gs, the heterotrimeric G protein that couples with heptahelical plasma membrane receptors. Whether the patient exhibits resistance to hormones or not is determined by the parental origin of the mutation, a functional maternal GNAS1 allele having a predominant role in preventing hormone resistance.

Expert reviewer(s)

  • Pr Jean-Claude CAREL
  • Pr Marie-Laure KOTTLER
  • Pr Agnès LINGLART

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.

Captcha image

Detailed information

Summary information
Guidance for genetic testing
  • EN (2013,pdf)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.